Related Experiment Video
Updated: May 19, 2026
09:41
Preparation and Immunostaining of Myelinating Organotypic Cerebellar Slice Cultures
Published on: March 20, 2019
Myosinopathies: pathology and mechanisms.
Homa Tajsharghi1, Anders Oldfors
1Department of Pathology, Institute of Biomedicine, University of Gothenburg, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Acta Neuropathologica
|August 25, 2012
Summary
Hereditary myosin myopathies result from mutations in myosin heavy chain (MyHC) genes, leading to muscle weakness and protein aggregation. Understanding these mutations is key to diagnosing and treating myosinopathies.
Area of Science:
- Muscle physiology and genetics
- Molecular biology
- Neuromuscular disorders
Background:
- Myosin heavy chain (MyHC) proteins are crucial for muscle contraction and fiber type differentiation.
- Mutations in MyHC genes cause a spectrum of hereditary myosin myopathies with diverse clinical presentations.
- Protein aggregation and motor function impairment are key pathogenic mechanisms.
Purpose of the Study:
- To review the clinical and morphological spectrum of hereditary myosin myopathies.
- To elucidate the role of different MyHC isoforms and mutation types in disease pathogenesis.
- To highlight the significance of protein aggregation and motor dysfunction in myosinopathies.
Main Methods:
- Review of existing literature on hereditary myosin myopathies.
- Analysis of genotype-phenotype correlations for various MyHC mutations.
- In vitro studies examining the biochemical and biophysical effects of specific mutations.
Main Results:
- Mutations in MYH3 and MYH8 are linked to distal arthrogryposis syndromes.
- MYH2 mutations cause early-onset myopathies with weakness and ophthalmoplegia.
- MYH7 mutations are associated with myopathies like myosin storage myopathy and Laing distal myopathy, often involving protein aggregation.
Conclusions:
- Hereditary myosin myopathies represent a significant group of genetic muscle diseases.
- Specific MyHC isoforms and mutation characteristics dictate disease phenotype.
- Defective protein degradation and impaired motor function contribute to myosinopathy pathogenesis.
Related Concept Videos
01:25Nervous Tissue: Myelin
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:15Neurogenesis and Regeneration of Nervous Tissue
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...